NCT05483010View on ClinicalTrials.gov

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

PHASE2RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Clonal Cytopenia of Undetermined SignificanceMyelodysplastic Syndromes
Interventions
DRUG

Atorvastatin

Atorvastatin is commercially available.

DRUG

Rosuvastatin

Rosuvastatin is commercially available.

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER